Literature DB >> 9046381

Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal.

P Hansson1, M Caron, G Johnson, L Gustavsson, C Alling.   

Abstract

Phosphatidylethanol (PEth) is formed only in the presence of ethanol, via the action of phospholipase D. We studied PEth in blood as a possible marker of alcohol abuse in 15 male alcoholics admitted for detoxification. Blood was drawn on the first day after admission and up to 28 days thereafter. PEth in whole blood was 13.2 +/- 2.2 mumol liter-1 (mean +/- SE) at first sampling and remained detectable up to 14 days after admission. Blood ethanol was 0 on the morning after admission. The time courses of PEth disappearance varied among individuals. No PEth could be found in blood of control persons who had abstained from ethanol for 4 days. Levels of PEth and carbohydrate-deficient transferrin or gamma-glutamyltranspeptidase did not correlate. Its high specificity and prolonged detectability suggest PEth in blood as a marker of recent alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046381

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  16 in total

Review 1.  Circulating cytokines as biomarkers of alcohol abuse and alcoholism.

Authors:  Rajeshwara N Achur; Willard M Freeman; Kent E Vrana
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

2.  Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.

Authors:  Andrew K Littlefield; Jennifer L Brown; Ralph J DiClemente; Polina Safonova; Jessica M Sales; Eve S Rose; Nikolay Belyakov; Vadim V Rassokhin
Journal:  AIDS Behav       Date:  2017-07

3.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

Review 4.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

5.  Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa.

Authors:  Stephen B Asiimwe; Robin Fatch; Nneka I Emenyonu; Winnie R Muyindike; Allen Kekibiina; Glenn-Milo Santos; Thomas K Greenfield; Judith A Hahn
Journal:  Alcohol Clin Exp Res       Date:  2015-07-04       Impact factor: 3.455

6.  Phosphatidylethanol and alcohol consumption in reproductive age women.

Authors:  Scott H Stewart; Tameeka L Law; Patrick K Randall; Roger Newman
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

7.  Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Authors:  Judith A Hahn; Loren M Dobkin; Bernard Mayanja; Nneka I Emenyonu; Isaac M Kigozi; Stephen Shiboski; David R Bangsberg; Heike Gnann; Wolfgang Weinmann; Friedrich M Wurst
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

8.  Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program.

Authors:  Paul Marques; Therese Hansson; Anders Isaksson; Lisa Walther; Joseph Jones; Douglas Lewis; Mary Jones
Journal:  Traffic Inj Prev       Date:  2011-04       Impact factor: 1.491

9.  Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.

Authors:  Martin A Javors; Nathalie Hill-Kapturczak; John D Roache; Tara E Karns-Wright; Donald M Dougherty
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

10.  Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.

Authors:  Scott H Stewart; Adrian Reuben; Walter A Brzezinski; David G Koch; Jan Basile; Patrick K Randall; Peter M Miller
Journal:  Alcohol Alcohol       Date:  2009-06-17       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.